Acquired resistance to BRAF inhibition induces epithelial-to-mesenchymal transition in BRAF (V600E) mutant thyroid cancer by c-Met-mediated AKT activation-Reference-Cited by-同舟云学术

Acquired resistance to BRAF inhibition induces epithelial-to-mesenchymal transition in BRAF (V600E) mutant thyroid cancer by c-Met-mediated AKT activation

Published:2016-11-21 Issue:1 Volume:8 Page:596-609
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Byeon Hyung Kwon¹,Na Hwi Jung¹,Yang Yeon Ju¹,Ko Sooah¹,Yoon Sun Och²,Ku Minhee³⁴,Yang Jaemoon³⁵,Kim Jae Wook⁶,Ban Myung Jin⁶,Kim Ji-Hoon⁷,Kim Da Hee¹,Kim Jung Min¹,Choi Eun Chang¹,Kim Chang-Hoon¹⁸,Yoon Joo-Heon¹⁸⁹,Koh Yoon Woo¹⁸

Affiliation:

1. Department of Otorhinolaryngology, Yonsei University College of Medicine, Seoul, Republic of Korea

2. Department of Pathology, Yonsei University College of Medicine, Seoul, Republic of Korea

3. Department of Radiology, Yonsei University College of Medicine, Seoul, Republic of Korea

4. Brain Korea 21 Plus Project for Medical Science, Yonsei University College of Medicine, Seoul, Republic of Korea

5. YUHS-KRIBB Medical Convergence Research Institute, Seoul, Republic of Korea

6. Department of Otorhinolaryngology, Soonchunhyang University College of Medicine, Republic of Korea

7. Department of Otorhinolaryngology-Head and Neck Surgery, Yonsei University Wonju College of Medicine, Wonju, Republic of Korea

8. The Airway Mucus Institute, Yonsei University College of Medicine, Seoul, Republic of Korea

9. Research Center for Human Natural Defense System, Yonsei University College of Medicine, Seoul, Republic of Korea

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of mitochondria and potential of mitochondria-targeted therapy in BRAF mutant cancer: A review;Critical Reviews in Oncology/Hematology;2024-11

2. The effects of Aurora Kinase inhibition on thyroid cancer growth and sensitivity to MAPK-directed therapies;Cancer Biology & Therapy;2024-03-23

3. Role and Function of Receptor Tyrosine Kinases in BRAF Mutant Cancers;Receptors;2024-03-04

4. MicroRNA-181b-5p Facilitates Thyroid Cancer Growth via Targeting Programmed Cell Death 4;Molecular Biotechnology;2024-01-22

5. Low-Density Lipoprotein Receptor Is a Key Driver of Aggressiveness in Thyroid Tumor Cells;International Journal of Molecular Sciences;2023-07-06